ARL14: Potential Drug Target and Biomarker (G80117)

Target Name: ARL14

NCBI ID: G80117

ARL14: Potential Drug Target and Biomarker

ARL14 (ARF7) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a part of the RNA-protein complex, known as the ribosomal subunit, that is responsible for the production of a variety of proteins in the cell.

One of the interesting things about ARL14 is its potential as a drug target or biomarker. The ARF7 protein has been shown to play a role in a variety of cellular processes, including cell signaling, DNA replication, and protein synthesis. As a result, ARL14 has been identified as a potential drug target for a variety of diseases.

One of the key benefits of ARL14 as a drug target is its high degree of cross-talk. ARL14 is expressed in many different tissues of the body, which means that it is likely to be involved in a wide range of physiological processes. This makes it an attractive target for drugs that can modulate its activity and have a beneficial effect on a variety of cellular processes.

In addition to its potential as a drug target, ARL14 has also been identified as a potential biomarker for a variety of diseases. For example, studies have shown that ARL14 is often elevated in the blood or urine of patients with a variety of diseases, including cancer, cardiovascular disease, and neurological disorders. This suggests that ARL14 may be a useful diagnostic or prognostic marker for these diseases.

Another potential benefit of ARL14 as a drug target is its ability to be targeted with small molecules. Because ARL14 is expressed in many different tissues of the body, it is likely to be involved in a wide range of cellular processes. This makes it an attractive target for drugs that can inhibit its activity and have a therapeutic effect on a variety of cellular processes.

In addition to its potential as a drug target and biomarker, ARL14 is also of interest to researchers because of its unique structure and biology. The ARF7 protein is part of the RNA-protein complex, which is a complex structure that is responsible for the production of a variety of proteins in the cell. This means that ARL14 has a unique way of interacting with other proteins in the cell, which could be an attractive target for drugs that can modulate its activity.

Overall, ARL14 is a protein that has a lot of potential as a drug target or biomarker. Its high degree of cross-talk, its potential as a diagnostic or prognostic marker, its ability to be targeted with small molecules, and its unique structure and biology make it an attractive target for a variety of diseases. Further research is needed to fully understand the role of ARL14 in cellular processes and its potential as a drug or biomarker.

Protein Name: ADP Ribosylation Factor Like GTPase 14

Functions: GTPase that recruits MYO1E to MHC class II-containing vesicles via the effector protein ARL14EP and hence controls the movement of these vesicles along the actin cytoskeleton in dendritic cells

More Common Targets